Efficacy, quality of life, and acceptability outcomes of atypical antipsychotic augmentation treatment for treatment-resistant depression: protocol for a systematic review and network meta-analysis

BACKGROUND: Major depressive disorder (MDD) is a debilitating and costly mental disorder. Although commercially available antidepressants have proliferated over the last 20 years, a substantial number of patients either do not respond adequately to these drugs or are unable to tolerate their adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yiyun, Zhou, Xinyu, Qin, Bin, Del Giovane, Cinzia, Zhang, Yuqing, Xie, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234739/
https://www.ncbi.nlm.nih.gov/pubmed/25373601
http://dx.doi.org/10.1186/2046-4053-3-133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234739/
https://www.ncbi.nlm.nih.gov/pubmed/25373601
http://dx.doi.org/10.1186/2046-4053-3-133

Ejemplares similares